Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

NCT00120705 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Anemia

Interventions

DRUG: darbepoetin alfa

Sponsor

Amgen